A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents

2009 ◽  
Vol 2009 ◽  
pp. 98-99
Author(s):  
M.S. Gordon
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Cell Cancer ◽  
Targeted Agents ◽  
Metastatic Renal Cell Cancer ◽  
Previously Treated

scholarly journals A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents

2008 ◽  
Vol 180 (3) ◽  
pp. 867-872 ◽  
Author(s):  
Nizar M. Tannir ◽  
Peter F. Thall ◽  
Chaan S. Ng ◽  
Xuemei Wang ◽  
Leiko Wooten ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Cell Cancer ◽  
Targeted Agents ◽  
Metastatic Renal Cell Cancer ◽  
Previously Treated

Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5047-5047 ◽  
Author(s):  
S. S. Sridhar ◽  
M. J. Mackenzie ◽  
S. J. Hotte ◽  
S. D. Mukherjee ◽  
C. Kollmannsberger ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Cell Cancer ◽  
Metastatic Renal Cell Cancer

scholarly journals Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial

1996 ◽  
Vol 73 (6) ◽  
pp. 789-793 ◽  
Author(s):  
JML Stouthard ◽  
H Goey ◽  
EGE de Vries ◽  
PH de Mulder ◽  
A Groenewegen ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Interleukin 6 ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Cell Cancer ◽  
Metastatic Renal Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document